הממלכה המאוחדת - אנגלית - myHealthbox

wockhardt uk ltd - sodium valproate - enteric coated tablet - 200mg - antiepileptics - in the treatment of generalised, partial or other epilepsy.

הממלכה המאוחדת - אנגלית - myHealthbox

wockhardt uk ltd - sodium valproate - enteric coated tablet - 500mg - antiepileptics - in the treatment of generalised, partial or other epilepsy.

מלטה - אנגלית - Malta Medicines Authority

wockhardt uk limited - oxytocin - concentrate for solution for infusion - oxytocin 10 iu - pituitary and hypothalamic hormones and analogues

ארצות הברית - אנגלית - NLM (National Library of Medicine)

wockhardt limited - octreotide acetate (unii: 75r0u2568i) (octreotide - unii:rwm8ccw8gp) - octreotide 50 ug in 1 ml - octreotide acetate injection is indicated to reduce blood levels of growth hormone and igf-i (somatomedin c) in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection, pituitary irradiation, and bromocriptine mesylate at maximally tolerated doses. the goal is to achieve normalization of growth hormone and igf-i (somatomedin c) levels (see dosage and administration). in patients with acromegaly, octreotide acetate reduces growth hormone to within normal ranges in 50% of patients and reduces igf-i (somatomedin c) to within normal ranges in 50%-60% of patients. since the effects of pituitary irradiation may not become maximal for several years, adjunctive therapy with octreotide acetate to reduce blood levels of growth hormone and igf-i (somatomedin c) offers potential benefit before the effects of irradiation are manifested. improvement in clinical signs and symptoms or reduction in tumor size or rate of growth were not shown in clinical trials performed with octre

ארצות הברית - אנגלית - NLM (National Library of Medicine)

wockhardt usa llc. - octreotide acetate (unii: 75r0u2568i) (octreotide - unii:rwm8ccw8gp) - octreotide 50 ug in 1 ml - octreotide acetate injection is indicated to reduce blood levels of growth hormone and igf-i (somatomedin c) in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection, pituitary irradiation, and bromocriptine mesylate at maximally tolerated doses. the goal is to achieve normalization of growth hormone and igf-i (somatomedin c) levels (see dosage and administration). in patients with acromegaly, octreotide acetate reduces growth hormone to within normal ranges in 50% of patients and reduces igf-i (somatomedin c) to within normal ranges in 50%-60% of patients. since the effects of pituitary irradiation may not become maximal for several years, adjunctive therapy with octreotide acetate to reduce blood levels of growth hormone and igf-i (somatomedin c) offers potential benefit before the effects of irradiation are manifested. improvement in clinical signs and symptoms or reduction in tumor size or rate of growth were not shown in clinical trials performed with octre

ארצות הברית - אנגלית - NLM (National Library of Medicine)

wockhardt usa llc. - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine 2.5 mg - felodipine extended-release tablets are indicated for the treatment of hypertension. felodipine extended-release tablets may be used alone or concomitantly with other antihypertensive agents. felodipine extended-release tablets are contraindicated in patients who are hypersensitive to this product.

ארצות הברית - אנגלית - NLM (National Library of Medicine)

wockhardt usa llc. - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine 150 mg - ranitidine tablets, usp are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. no placebo-controlled comparative studies have been carried out for periods of longer than 1 year. - the treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome and systemic mastocytosis). -  short-term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. - maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. placebo-controlled studies have been carried ou

קניה - אנגלית - Pharmacy and Poisons Board

wockhardt ltd wockhardt limited, wockhardt towers, bandra- - kantakari mool 30mg (solanum xanthocarpum)… - capsule, hard - kantakari mool 30mg (solanum xanthocarpum)… - all other therapeutic products

ארצות הברית - אנגלית - NLM (National Library of Medicine)

wockhardt limited - clopidogrel bisulfate (unii: 08i79htp27) (clopidogrel - unii:a74586sno7) - clopidogrel 75 mg - - for patients with non-st-segment elevation acs [unstable angina (ua)/non-st-elevation myocardial infarction (nstemi)], including patients who are to be managed medically and those who are to be managed with coronary revascularization, clopidogrel tablet has been shown to decrease the rate of a combined endpoint of cardiovascular death, myocardial infarction (mi), or stroke as well as the rate of a combined endpoint of cardiovascular death, mi, stroke, or refractory ischemia. - for patients with st-elevation myocardial infarction (stemi), clopidogrel tablet has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction, or stroke. the benefit for patients who undergo primary percutaneous coronary intervention is unknown. the optimal duration of clopidogrel tablets therapy in acs is unknown. for patients with a history of recent myocardial infarction (mi), recent stroke, or established peripheral arterial disease, clopidogrel tablet has been shown to redu

קניה - אנגלית - Pharmacy and Poisons Board

wockhardt limited wockhardt tower bandra-kurla complex bandra east - terbutaline sulphate bromhexine hcl guaifenesin… - oral liquid - each 10 ml contains:terbutaline sulphate bp 2.5… - expectorants excluding combinations with cough